Jong, S. de

tumor immunotherapy t cells mesothelioma cancer journal cyclophosphamide tumor-bearing mice survival signi blood lymph nodes 25+ treatment dc-based immunotherapy administration figure drinking water signi ficantly dendritic response fl ow cytometry tumor-bearing model day 10 low-dose antitumor e ffect day 3 murine immunity function patient dc-based group day 14 lymph tumor growth water ficantly robinson percentage immunology drinking biotechnology antibody biomedicine murine model low-dose ctx ctx administration proportion staining mechanism mouse signi ficant increase dendritic cell-based immunotherapy di fferent ratios balb /c mice weight metronomic combination ficant foxp 3 concentration low-dose cyclophosphamide control bd biosciences splenocyte granzyme cytotoxic netherland expression 2005. research antigen 2006. spleen regression tissue lysate